Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Asklepion Pharmaceuticals

Asklepion Pharmaceuticals
2006 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Corporate LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a pharmaceutical company engaged in the research and development. The company mainly focuses on different types of liver-based diseases.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Primary Office
  • 729 East Pratt Street
  • Suite 360
  • Baltimore, MD 21202
  • United States

+1 (410) 000-0000

Asklepion Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Asklepion Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Asklepion Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Asklepion Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Asklepion Pharmaceuticals Executive Team (4)

Name Title Board
Seat
Contact
Info
Gary Pasternack Ph.D Chief Executive Officer
Kenneth Setchell Ph.D Chief Scientific Officer
Gary Pyner Sr. Chief Commercial Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »